Skip to content

Drug interactions

Ledipasvir-sofosbuvir + Tenofovir df

Severity: Moderate

Ledipasvir-sofosbuvir and Tenofovir df: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ledipasvir/sofosbuvir increases tenofovir exposure, which can raise the risk of kidney injury and bone mineral density loss. The risk is greater with other nephrotoxins or pre-existing renal impairment.

What this interaction means in plain words

Ledipasvir-sofosbuvir and Tenofovir df can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: High

Why it happens

P-gp and BCRP inhibition by ledipasvir increases intestinal absorption of tenofovir.

What to do

Monitor renal function, urinalysis and serum phosphate during therapy; consider an alternative such as tenofovir alafenamide in high-risk patients.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ledipasvir-sofosbuvir and Tenofovir df, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ledipasvir-sofosbuvir with Tenofovir df?

MediHelp rates the interaction as moderate. Ledipasvir-sofosbuvir and Tenofovir df can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ledipasvir/sofosbuvir increases tenofovir exposure, which can raise the risk of kidney injury and bone mineral density loss. The risk is greater with other nephrotoxins or pre-existing renal impairment.

How serious is the interaction between Ledipasvir-sofosbuvir and Tenofovir df?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor renal function, urinalysis and serum phosphate during therapy; consider an alternative such as tenofovir alafenamide in high-risk patients.

What other medicines interact with Ledipasvir-sofosbuvir?

MediHelp also lists interactions of Ledipasvir-sofosbuvir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Ledipasvir-sofosbuvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in